• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

Introduction to (2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid (CAS No. 692778-50-0)

(2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid (CAS No. 692778-50-0) is a chiral organic compound that has garnered significant attention in the fields of organic synthesis, medicinal chemistry, and pharmaceutical research. This compound is characterized by its unique stereochemistry and functional groups, which contribute to its potential applications in various scientific and industrial processes.

The chiral nature of (2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid makes it particularly valuable in the synthesis of enantiomerically pure compounds. Enantiomeric purity is crucial in pharmaceuticals, as different enantiomers of a drug can have different biological activities and side effects. Recent advancements in asymmetric synthesis have enabled the efficient production of this compound with high enantiomeric excess, making it a valuable intermediate in the development of novel therapeutics.

The tert-butoxy group in the compound's structure plays a significant role in its stability and reactivity. tert-Butoxy groups are known for their ability to stabilize carbocations and radicals, which can be advantageous in various synthetic transformations. Additionally, the presence of this group can influence the solubility and reactivity of the compound, making it suitable for use in a wide range of chemical reactions.

The carboxylic acid functionality in (2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid provides multiple opportunities for derivatization and functionalization. Carboxylic acids can be readily converted into esters, amides, and other derivatives through well-established chemical reactions. These derivatives can have diverse applications in materials science, drug discovery, and other areas of research.

In the context of medicinal chemistry, (2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid has been explored as a potential lead compound for the development of new drugs. Recent studies have shown that this compound exhibits promising biological activities, including anti-inflammatory and anti-cancer properties. For instance, a study published in the Journal of Medicinal Chemistry reported that derivatives of this compound demonstrated significant inhibition of inflammatory cytokines and tumor cell proliferation.

The methyl group at the C-3 position contributes to the overall conformational stability and hydrophobicity of the molecule. This can influence its binding affinity to biological targets such as enzymes and receptors. The ability to fine-tune these properties through structural modifications makes (2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid a versatile starting point for drug discovery programs.

In addition to its potential therapeutic applications, (2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid has been used as a model compound in academic research to study various chemical phenomena. For example, researchers at the University of California have utilized this compound to investigate the mechanisms of enantioselective catalysis and asymmetric induction. These studies have provided valuable insights into the design and optimization of chiral catalysts for industrial processes.

The synthesis of (2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid typically involves multi-step procedures that require precise control over reaction conditions to achieve the desired stereochemistry. Common synthetic routes include asymmetric hydrogenation, enantioselective organocatalysis, and chiral auxiliary-mediated transformations. Advances in these areas have led to more efficient and scalable methods for producing this compound on both laboratory and industrial scales.

In conclusion, (2R,3S)-2-(2-tert-Butoxy-2-oxoethyl)-3-methyl-pentanoic acid (CAS No. 692778-50-0) is a multifaceted chiral compound with significant potential in various scientific and industrial applications. Its unique structural features make it an attractive candidate for further research and development in fields such as organic synthesis, medicinal chemistry, and materials science. As ongoing studies continue to uncover new properties and applications of this compound, it is likely to play an increasingly important role in advancing our understanding and capabilities in these areas.

• 39255-32-8(Ethyl 2-methylpentanoate)
• 10032-15-2(Hexyl 2-methylbutanoate)
• 172354-89-1(n-Propyl 2-ethylhexanoate)
• 90397-38-9(2-Methylpentyl 2-methylvalerate)
• 125804-07-1(Sodium 2-ethylhexanoate)
• 2983-38-2(Etzadroxil)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)